Abraham and Cho examine the complex interactions at the host-microbial interface in the intestinal tract, highlighting how normal intestinal bacteria coexist with intestinal immune system in critical relationship determining health and disease. The vast array of microorganisms inhabiting the human intestine requires multiple protective mechanisms including mucus layer, antimicrobial peptides, immunoglobulin A (IgA), epithelial cell barriers, and immune cells within the intestine. This sophisticated host-microbial interaction reflects complex coevolution where intestinal bacteria have adapted to survive in the intestinal environment while host immune system has adapted to tolerate beneficial bacteria while preventing pathogenic organisms from damaging the body. Deciphering how cross-talk occurs at the host-microbial interface may yield insights into disease development when this relationship breaks down.
Abraham and Cho discuss how intestinal microbiome composition and function are essential for normal intestinal immune development and maintenance of homeostasis. Specific bacterial species and metabolites they produce shape immune system development, with certain bacteria promoting regulatory immune responses while others promote inflammatory responses. When microbiome composition becomes abnormal (dysbiosis) or when intestinal barrier function deteriorates (leaky gut), dysregulated immune responses can develop that trigger or exacerbate autoimmune disease. The research emphasizes that intestinal health fundamentally depends on appropriate bacterial colonization and functional barrier preventing bacterial products from entering systemic circulation.
For MS patients, this research emphasizes that intestinal health and microbiome function likely influence MS disease activity through effects on immune system development and regulation. MS patients should support healthy intestinal bacteria through probiotic foods and supplements, prebiotic fiber consumption, and dietary practices promoting beneficial bacteria. Patients should also address intestinal barrier integrity through adequate fiber, reduced inflammation-promoting foods, and stress reduction supporting intestinal health. The research suggests that dysfunctional intestinal microbiota might contribute to MS pathogenesis, supporting comprehensive intestinal health optimization as component of disease management.
